The Qatari Ministry of Health announced the withdrawal of all shipments of the Ferinject 50 mg product due to its non-compliance with chemical specifications.
Hot Topics
The ministry said in a statement carried by local media that the withdrawal came after the results of laboratory tests conducted by the ministry's laboratories confirmed that the product did not conform to the chemical specifications set by the company.
According to specialized medical websites, the scientific name of the preparation is iron carboxymaltose, and it is used to treat iron deficiency anemia in patients who have not tolerated orally administered iron or have not had a good response to it, as well as in chronic kidney patients who are not undergoing dialysis.
The product contains iron, which contributes to the formation of hemoglobin in red blood cells and myoglobin in muscles, and is involved in the transport of oxygen and carbon dioxide in the blood, supporting the immune system and producing energy.
what is your opinion on this news ?do let us know in the comments on tha comment box
if you liked this news article please share on friends & family & don't forget to follow on website & social media
